Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
279.82
+0.82 (0.29%)
May 14, 2025, 2:44 PM - Market open
Revenue by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
US Human Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Human Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Animal Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Animal Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Healthcare Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Healthcare Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total US Healthcare Solutions | 281.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total US Healthcare Solutions Growth | 13.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total International Healthcare Solutions | 29.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total International Healthcare Solutions Growth | 2.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Alliance Healthcare | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Alliance Healthcare Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
Pharmaceutical Distribution Services Segment Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Distribution Services Segment Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Segment Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Segment Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Healthcare Solutions Operating Income | 3.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Healthcare Solutions Operating Income Growth | 13.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Healthcare Solutions Operating Income | 674.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Healthcare Solutions Operating Income Growth | -8.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|